Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2018; 54(01): 054-061
DOI: 10.1055/s-0040-1712822
Original Article

HEV-related Liver Disease in India : Why is the Disease Stormy?

Premashis Kar
Department of Gastroenterology and Hepatology, Max Super Specialty Hospital, Ghaziabad
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Hepatitis E virus (HEV) is an important cause of epidemic and sporadic acute viral hepatitis (AVH) in many developing countries, including India. Hepatitis E, a positive-sense single-stranded RNA virus approximately 7.2 kb in length had been classified provisionally into the Caliciviridae family from 1988 to 1998 but HEV is currently placed in the genus Hepevirus and is the only member of the family Hepeviridae. Pregnant women with jaundice and AVH caused by HEV infection have worse fetal and obstetric outcome and higher maternal mortality compared to other types of viral hepatitis. Studies from various developing countries have shown that the incidence of HEV infection in pregnancy is high and a significant proportion of pregnant women can progress to fulminant hepatitis with a mortality rate varying from 30% to 100%. The incidence of hepatitis B virus (HBV) related acute liver failure is known widely in comparison to hepatitis C virus (HCV) infection in which acute liver failure (ALF) is rare. But the severe course of HEV infection causing ALF during pregnancy is unique to this virus with chronicity occurring in recipients of solid organ transplants.

Various factors have been suggested to be associated with the mortality rate of the HEV in pregnant women along with the abortion of the fetus. Steroid hormones play a significant role in the viral replication through their effects on viral regulatory elements. The NF-κB signaling pathway regulating at the transcriptional level through p50 subunits has been suggested to correlate with the severe liver damage, leading to multiple organ failure and the death of both the mother and the fetus. Pregnant women in Asia suffer from folate deficiency reducing the immunocompetence to greater risk of multiple viral infections and higher viral load. The viral load of HEV was found to be significantly higher (P < 0.05) in pregnant patients compared to the non-pregnant and the viral copies of HEV with fulminant hepatic failure (FHF) in pregnant women were comparatively higher when compared to the pregnant women with AVH, which may be related to the severity of the disease in these patients. Besides, reduced expression of progesterone and progesterone induced-blocking factor and the high viral load of HEV have been regarded as a cause of poor pregnancy outcome in hepatitis E infection. Vertical transmission of the HEV infection has been reported. There are published reports of abortion, death of the fetus in utero, premature delivery or death of the baby soon after birth in patients with icteric hepatitis or with ALF caused by HEV. However, studies in Europe and United States have shown the course of viral hepatitis during pregnancy resembling with the non-pregnant women. In contrast, various reports carried out in India, Iran, Africa, and Middle East have reported the incidence of ALF to be higher during pregnancy.

Data on the viral load of HEV during pregnancy are limited. The study was designed to determine the viral load of HEV and its association with the disease severity in patients with ALF. A total HEV related 163 patients with ALF which included 105 pregnant, 46 non-pregnant women and girls, 12 men, and 730 patients with AVH which comprised of 220 pregnant women; 282 non-pregnant women and girls, and 228 men were included. Viral load was measured by real-time PCR. Comparison was made between the pregnant and non-pregnant women. HEV RNA was detectable in 265 patients (142 pregnant; 75 non-pregnant and 48 men) and 104 patients with ALF (64 pregnant, 34 non-pregnant and 6 men). The viral load of HEV in pregnant women with ALF and AVH was significantly higher 129,984.0±103,104.17 and 768.92±1,105.40 copies/ml, respectively compared to the non-pregnant women which was 189.2±225 and 12.73±7.8 copies/ml (P < 0.0001). The viral load of HEV was also significantly higher in the pregnant patients with ALF compared to the pregnant women with AVH and also men (P < 0.0001). High viral load of HEV during pregnancy could be one of the factors responsible for the severity of the infection during pregnancy.

Keywords

Immunocompetence - HEV during pregnancy - acute liver failure - acute viral hepatitis

DR. R.V. RAJAM ORATION delivered during NAMSCON 2017 at Sri Guru Ram Das Institute of Medical Sciences & Research, Sri Amritsar, Punjab.




Publication History

Article published online:
08 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Viswanathan R (1957). Infectious hepatitis in Delhi (1955–56): a critical study-epidemiology. Indian J Med Res 45:1–29.
  • 2 Dhamdhere MR, Nadkarni MG (1962). Infectious hepatitis at Aurangabad: report of an outbreak. Indian J Med Sci 16:1006–1015.
  • 3 Bhattacharji LM , Saha AL, Sampathkumaran MA, De SK (1963). Investigation of an outbreak of infectious hepatitis in a small town in West Bengal during July–October, 1960. Indian J Med Res 51:550–562.
  • 4 Pattanayak S, Singha P, Pal SC, Rao CK, Shrivastav JB (1968). An outbreak of infectious hepatitis in Siliguri, 1966. Indian J Med Res 56:1605–1616.
  • 5 Khuroo MS (1980). Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68:818–824.
  • 6 Naik SR, Aggarwal R, Salunke PN, Mehrotra NN (1992). A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull WHO 70:597–604.
  • 7 Ray R, Talwar GP, Aggarwal R, Salunke PN, Naik SR, Mehrotra NN (1991). Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet 338:783–784.
  • 8 Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM (1980). Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 2:876–879.
  • 9 Acharya SK, Batra Y, Bhatkal B, et al (2003). Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol 18:822–827.
  • 10 Skidmore SJ, Yarbough PO, Gabor KA, Tam AW, Reyes GR (1992). Hepatitis E virus: the cause of a waterborne hepatitis outbreak. J Med Virol 37:58–60.
  • 11 Tam AW, Smith MM, Guerra ME, et al (1991). Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131.
  • 12 Sreenivasan MA, Banerjee K, Pandya PG, et al (1978). Epidemiological investigations of an outbreak of infectious hepatitis in Ahmedabad city during 1975–76. Indian J Med Res 67:197–206.
  • 13 Khuroo MS, Duermeyer W, Zargar SA, Ahanger MA, Shah MA (1983). Acute sporadic non-A, non-B hepatitis in India. Am J Epidemiol 118:360–364.
  • 14 Tandon BN, Joshi YK, Jain SK, Gandhi BM, Mathiesen LR, Tandon HD (1982). An epidemic of non-A, non-B hepatitis in North India. Indian J Med Res 75:739-744.
  • 15 Sreenivasan MA, Arankalle VA, Sehgal A, Pavri KM (1984). Non-A, non-B epidemic hepatitis: visualization of virus-like particles in the stool by immune electron microscopy. J Gen Virol 65:1005–1007.
  • 16 Arankalle VA , Ticehurst J, Sreenivasan MA, et al (1988). Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis. Lancet 1:550–554.
  • 17 Panda SK, Datta R, Kaur J, Zuckerman AJ, Nayak NC (1989). Enterically transmitted non-A, non-B hepatitis: recovery of viruslike particles from an epidemic in south Delhi and transmission studies in rhesus monkeys. Hepatology 10:466–472.
  • 18 Datta R, Panda SK, Tandon BN, et al (1987). Acute sporadic non-A, non-B viral hepatitis of adult in India: epidemiological and immunological studies. J Gastroenterol Hepatol 2:333–345.
  • 19 Chauhan A, Dilawari JB, Jameel S, et al (1992). Common aetiological agent for epidemic and sporadic non-A, non-B hepatitis. Lancet 339:1509–1510.
  • 20 Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK (1994). Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 42:133–137.
  • 21 Madan K, Gopalkrishna V, Kar P, Sharma JK, Das UP, Das BC (1998). Detection of hepatitis C and E virus genomes in sera of patients with acute viral hepatitis and fulminant hepatitis by their simultaneous amplification in PCR. J Gastroenterol Hepatol 13:125–130.
  • 22 Acharya SK, Panda SK, Saxena A, Gupta SD (2000). Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 15:473–479.
  • 23 Tandon BN, Gandhi BM, Joshi YK (1984). Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull WHO 62:67–73.
  • 24 Tandon BN, Gupta H, Irshad M, Joshi YK, Chawla TC (1984). Associated infection with non-A, non-B virus as possible cause of liver failure in Indian HBV carriers. Lancet 2:750–751.
  • 25 Monga R, Garg S, Tyagi P, Kumar N (2004). Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol 23:50–52.
  • 26 Bradley DW (1990). Enterically-transmitted non-A, non-B hepatitis. Br Med Bull 46:442–461.
  • 27 Aggarwal R, Naik SR (1994). Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol 21:718–723.
  • 28 Panda SK, Acharya SK (1998). Hepatitis E virus infection: where are we? Natl Med J India 11:56–58.
  • 29 Arankalle VA, Chadha MS, Mehendale SM, Tungatkar SP (2000). Epidemic hepatitis E: serological evidence for lack of intrafamilial spread. Indian J Gastroenterol 19:24–28.
  • 30 Khuroo MS, Kamili S, Yattoo GN (2004). Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 19:778–784.
  • 31 Wang JT, Lin JT, Sheu JC, Wang TH, Chen DS (1994). Hepatitis E virus and posttransfusion hepatitis. J Infect Dis 169:229–230.
  • 32 Aggarwal R (2004). Hepatitis E: is it a blood-borne pathogen? J Gastroenterol Hepatol 19:729–731.
  • 33 Robson SC, Adams S, Brink N, Woodruff B, Bradley D (1992). Hospital outbreak of hepatitis E. Lancet 339:1424–1425.
  • 34 Arankalle VA, Chobe LP (1999). Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat 6:161–164.
  • 35 Mathur P, Arora NK, Panda SK, Kapoor SK, Jailkhani BL, Irshad M (2001). Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India. Indian Pediatr 38:461–475.
  • 36 Arora NK, Nanda SK, Gulati S, et al (1996). Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 48:215–221.
  • 37 Chuttani HK, Sidhu AS, Wig KL, Gupta DN, Ramalingaswami V (1966). Follow-up study of cases from the Delhi epidemic of infectious hepatitis of 1955–56. Br Med J 2:676–679.
  • 38 Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI (1981). Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252-255.
  • 39 Khuroo MS, Kamili S (2003). Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 10:61-69.
  • 40 Khuroo MS, Kamili S, Jameel S (1995). Vertical transmission of hepatitis E virus. Lancet 345:1025-1026.
  • 41 Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L (2001). Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 100:9-15.
  • 42 Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK (2003). Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 70:37-39.
  • 43 Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS (2004). Hepatitis E in pregnancy. Int J Gynecol Obstet 85:240–244.
  • 44 Dahiya M, Kumar A, Kar P, Gupta RK, Kumar A (2005). Acute viral hepatitis in third trimester of pregnancy. Indian J Gastroenterol 24:128–129.
  • 45 Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK (2007). Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 147: 28-33.
  • 46 Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS (2001). Viral hepatitis during pregnancy. Int J Gynaecol Obstet 72:103-108.
  • 47 Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P (2013). Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy. J Med Virol 85: 622-626.
  • 48 Aziz AB, Hamid S, Iqbal S, Islam W, Karim SA (1997). Prevalence and severity of viral hepatitis in Pakistani pregnant women: a five year hospital based study. J Pak Med Assoc 47:198-201.
  • 49 Purcell RH, Emerson SU (2001). Hepatitis E virus. In: Fields Virology, 4th edn. Knipe DM, Howley PM, eds. Philadelphia: Lippincott Williams & Wilkins, 3051–3061.
  • 50 Aggarwal R, Krawczynski K (2000). Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 15:9-20.
  • 51 McGovern BH, Diteberg JS, Taylor LE, et al (2006). Hepatic Steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 43:365–372.
  • 52 Mellor AM, Munn DH (1999). Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469–473.
  • 53 Siebenlist U, Franzoso G, Brown K (1994). Structure, regulation and function of NF-kappa B. Ann Rev Cell Biol 10:405–455.
  • 54 Jilani N, Das BC, Husain SA, et al (2007). Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 22:676–682.
  • 55 Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S (2005). Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 20:1094–1101.
  • 56 Fried M, Duffy PE (1996). Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272:1502–1504.
  • 57 Morell V (1995). Zeroing in on how hormones affect the immune system. Science 269:773–775.
  • 58 Singh N, Shukla MM, Sharma VP (1999). Epidemiology of malaria in pregnancy. Bull WHO 77:567-572.
  • 59 Matthiesen L, Berg G, Ernerudh J, Hakansson L (1996). Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol 35:70–79.
  • 60 Kar P, Jilani N, Husain SA, et al (2008). Does hepatitis E viral load and genotypes influence the final out- come of acute liver failure during pregnancy? Am J Gastroenterol 103:2495-2501.
  • 61 Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P (2011). High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J Hepatol 54: 1107-1113.
  • 62 Purcell RH, Emerson SU (2008). Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503.
  • 63 Zhu G, Qu Y, Jin N, et al (2008). Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China. Infection 36:140-146.
  • 64 Ijaz S, Arnold E, Banks M, et al (2005). Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 192:1166-1172.